Form 4: Kura Oncology Executive Sells Shares
Insider Transaction (Form 4)
Teresa Brophy Bair, Chief Legal Officer of Kura Oncology, Inc., sold 8,442 shares of common stock on September 28, 2026 for $10.50 per share.
Summary
- Open-market sale: disposed of 8,442 Common Stock at $10.50 ($88,618) on September 28, 2026; holds 187,002 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $88,618 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Teresa Brophy Bair — Officer (Chief Legal Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market sale | Common Stock | 8,442 | $10 | $88.6K | 187,002 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market sale (8,442 shares) |
Keywords
insider transaction, Form 4, KURA, Kura Oncology, Inc., bearish, Teresa Brophy Bair
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.